← Leaderboards
Daniel C Link
Washington University
$19,842,999
Attributed
$20,059,436
Total exposure
16
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$47,316,918 · 17
By mechanism
P50$29,553,036 · 6
R01$12,300,661 · 6
P01$3,829,120 · 2
RC1$999,078 · 1
R21$432,875 · 1
P30$202,148 · 1
Top collaborators
- Stephen Tracy Oh2 shared
Most similar at Washington University
Same institution · by research overlap
- Geoffrey L Uy$4,632,267
- Timothy A Graubert$17,171,795
- Timothy J Ley$36,060,228
- Grant Anthony Challen$8,869,510
- Alessandro Vindigni$5,609,059
Others in their field
Top investigators on “Leukemia”
- Richard K. Wilson · Washington University$209,620,938
- David Heimbrook · Leidos Biomedical Research, Inc.$168,419,678
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,967,203
- Peter C Adamson · National Childhood Cancer Foundation$143,910,899
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- Richard L Schilsky · University Of Chicago$129,102,207
Research focus
LeukemiaMutationCollaborationsProgramsResearch PersonnelHematopoiesisCellsUniversitiesWashingtonMolecularGenomicsGenesResponseMeetingsMinorityBone MarrowSpecialized Program Of Research ExcellenceTranslational ResearchBasic ScienceDysmyelopoietic SyndromesInstitutionHematopoietic Stem CellsMutateMentors
Grant awards (99)
Specialized Program of Research Excellence (SPORE) in Leukemia$2,183,320
P50 · FY2025 · CA · contact PI
Project 4: Targeting ATR in TP53-mutated MDS/AML$349,875
P50 · FY2025 · CA · contact PI
Administrative Core$56,716
P50 · FY2025 · CA · contact PI
Specialized Program of Research Excellence (SPORE) in Leukemia$2,109,864
P50 · FY2024 · CA · contact PI
Project 4: Targeting ATR in TP53-mutated MDS/AML$335,882
P50 · FY2024 · CA · contact PI
Administrative Core$54,447
P50 · FY2024 · CA · contact PI
Specialized Program Of Research Excellence (SPORE) in Leukemia.$918,606
P50 · FY2023 · CA · contact PI
Project 4 - Genomics of TP53-mutant AML.$430,945
P01 · FY2023 · CA · contact PI
Identification of new genetic causes of congenital neutropenia$393,750
R01 · FY2023 · HL · contact PI
Administrative Core$103,502
P50 · FY2023 · CA · contact PI
DRP$29,674
P50 · FY2023 · CA · contact PI
Specialized Program Of Research Excellence (SPORE) in Leukemia.$2,127,879
P50 · FY2022 · CA · contact PI
Project 4 - Genomics of TP53-mutant AML.$431,738
P01 · FY2022 · CA · contact PI
Identification of new genetic causes of congenital neutropenia$393,750
R01 · FY2022 · HL · contact PI
DRP$73,092
P50 · FY2022 · CA · contact PI
Administrative Core$64,798
P50 · FY2022 · CA · contact PI
Specialized Program Of Research Excellence (SPORE) in Leukemia.$2,035,962
P50 · FY2021 · CA · contact PI
Project 4 - Genomics of TP53-mutant AML.$436,939
P01 · FY2021 · CA · contact PI
Identification of new genetic causes of congenital neutropenia$393,750
R01 · FY2021 · HL · contact PI
Single Cell Spatial Characterization of the Human Bone Marrow Microenvironment$196,875
R21 · FY2021 · HL
DRP$39,804
P50 · FY2021 · CA · contact PI
Administrative Core$32,123
P50 · FY2021 · CA · contact PI
Specialized Program Of Research Excellence (SPORE) in Leukemia.$2,184,998
P50 · FY2020 · CA · contact PI
Project 4 - Genomics of TP53-mutant AML.$442,330
P01 · FY2020 · CA · contact PI
Identification of new genetic causes of congenital neutropenia$393,541
R01 · FY2020 · HL · contact PI
Single Cell Spatial Characterization of the Human Bone Marrow Microenvironment$236,000
R21 · FY2020 · HL
DRP$72,431
P50 · FY2020 · CA · contact PI
Administrative Core$64,205
P50 · FY2020 · CA · contact PI
Specialized Program Of Research Excellence (SPORE) in Leukemia.$2,117,606
P50 · FY2019 · CA · contact PI
REGULATION OF HEMATOPOIETIC NICHES BY TGF FAMILY SIGNALING$381,250
R01 · FY2019 · HL · contact PI
Project 4 - Genomics of TP53-mutant AML.$238,505
P01 · FY2019 · CA · contact PI
DRP$70,917
P50 · FY2019 · CA · contact PI
Administrative Core$62,858
P50 · FY2019 · CA · contact PI
Specialized Program Of Research Excellence (SPORE) in Leukemia.$5,264
P50 · FY2019 · CA · contact PI
Administrative Core$5,264
P50 · FY2019 · CA · contact PI
Specialized Program Of Research Excellence (SPORE) in Leukemia.$2,299,839
P50 · FY2018 · CA · contact PI
REGULATION OF HEMATOPOIETIC NICHES BY TGF FAMILY SIGNALING$381,250
R01 · FY2018 · HL · contact PI
Genomics of Teatment-Related AML$180,579
P01 · FY2018 · CA · contact PI
DRP$76,103
P50 · FY2018 · CA · contact PI
Administrative Core$67,456
P50 · FY2018 · CA · contact PI
Specialized Program Of Research Excellence (SPORE) in Leukemia.$66,323
P50 · FY2018 · CA · contact PI
DRP$6,633
P50 · FY2018 · CA · contact PI
Administrative Core$6,631
P50 · FY2018 · CA · contact PI
Specialized Program Of Research Excellence (SPORE) in Leukemia$2,300,000
P50 · FY2017 · CA · contact PI
REGULATION OF HEMATOPOIETIC NICHES BY TGF FAMILY SIGNALING$381,250
R01 · FY2017 · HL · contact PI
Genomics of Teatment-Related AML$334,581
P01 · FY2017 · CA · contact PI
Core C: ADMINISTRATION$119,439
P50 · FY2017 · CA · contact PI
Specialized Program Of Research Excellence (SPORE) in Leukemia$68,242
P50 · FY2017 · CA · contact PI
Specialized Program Of Research Excellence (SPORE) in Leukemia$63,040
P50 · FY2017 · CA · contact PI
Specialized Program Of Research Excellence (SPORE) in Leukemia$2,162,000
P50 · FY2016 · CA · contact PI
REGULATION OF HEMATOPOIETIC NICHES BY TGF FAMILY SIGNALING$381,250
R01 · FY2016 · HL · contact PI
Genomics of Teatment-Related AML$336,859
P01 · FY2016 · CA · contact PI
Core C: ADMINISTRATION$112,272
P50 · FY2016 · CA · contact PI
Specialized Program Of Research Excellence (SPORE) in Leukemia$61,802
P50 · FY2016 · CA · contact PI
Specialized Program Of Research Excellence (SPORE) in Leukemia$2,183,943
P50 · FY2015 · CA · contact PI
Genomics of Teatment-Related AML$336,205
P01 · FY2015 · CA · contact PI
Core C: ADMINISTRATION$163,179
P50 · FY2015 · CA · contact PI
Specialized Program Of Research Excellence (SPORE) in Leukemia$55,795
P50 · FY2015 · CA · contact PI
Specialized Program Of Research Excellence (SPORE) in Leukemia$2,161,999
P50 · FY2014 · CA · contact PI
ROLE OF THE G-CSF RECEPTOR IN PROGENITOR MOBILIZATION$372,400
R01 · FY2014 · HL · contact PI
Genomics of Teatment-Related AML$325,498
P01 · FY2014 · CA · contact PI
Core C: ADMINISTRATION$167,550
P50 · FY2014 · CA · contact PI
Hematopoietic Developmental Malignancy$61,006
P30 · FY2014 · CA · contact PI
Specialized Program Of Research Excellence (SPORE) in Leukemia$2,151,000
P50 · FY2013 · CA · contact PI
ROLE OF THE G-CSF RECEPTOR IN PROGENITOR MOBILIZATION$361,760
R01 · FY2013 · HL · contact PI
Genomics of Teatment-Related AML$334,941
P01 · FY2013 · CA · contact PI
CLONAL DOMINANCE OF HEMATOPOIETIC STEM CELLS EXPRESSING MUTANT CSF3R$287,582
R01 · FY2013 · CA · contact PI
Patient Advocate$160,703
P50 · FY2013 · CA · contact PI
Hematopoietic Developmental Malignancy$60,202
P30 · FY2013 · CA · contact PI
ROLE OF THE G-CSF RECEPTOR IN PROGENITOR MOBILIZATION$380,000
R01 · FY2012 · HL · contact PI
CLONAL DOMINANCE OF HEMATOPOIETIC STEM CELLS EXPRESSING MUTANT CSF3R$305,938
R01 · FY2012 · CA · contact PI
Hematopoietic Developmental Malignancy$62,816
P30 · FY2012 · CA · contact PI
Hematopoietic Developmental Malignancy$2,779
P30 · FY2012 · CA · contact PI
ROLE OF THE G-CSF RECEPTOR IN PROGENITOR MOBILIZATION$380,000
R01 · FY2011 · HL · contact PI
CLONAL DOMINANCE OF HEMATOPOIETIC STEM CELLS EXPRESSING MUTANT CSF3R$305,938
R01 · FY2011 · CA · contact PI
Hematopoietic Developmental Malignancy$7,481
P30 · FY2011 · CA · contact PI
MUTATIONAL PROFILING OF MIRNAS IN AML$499,361
RC1 · FY2010 · CA · contact PI
CLONAL DOMINANCE OF HEMATOPOIETIC STEM CELLS EXPRESSING MUTANT CSF3R$315,400
R01 · FY2010 · CA · contact PI
Hematopoietic Developmental Malignancy$7,864
P30 · FY2010 · CA · contact PI
MUTATIONAL PROFILING OF MIRNAS IN AML$499,717
RC1 · FY2009 · CA · contact PI
CLONAL DOMINANCE OF HEMATOPOIETIC STEM CELLS EXPRESSING MUTANT CSF3R$315,400
R01 · FY2009 · CA · contact PI
Molecular Pathogenesis of Severe Congential Neutropenia$326,412
R01 · FY2008 · HL · contact PI
G-CSF receptor in progenitor mobilization$301,692
R01 · FY2008 · HL · contact PI
Molecular Pathogenesis of Severe Congential Neutropenia$326,412
R01 · FY2007 · HL · contact PI
G-CSF receptor in progenitor mobilization$295,832
R01 · FY2007 · HL · contact PI
STEM CELL MOBILIZATION TO ENHANCE TISSUE REGENERATION$526,086
R01 · FY2006 · HL · contact PI
Molecular Pathogenesis of Severe Congential Neutropenia$336,161
R01 · FY2006 · HL · contact PI
G-CSF receptor in progenitor mobilization$298,809
R01 · FY2006 · HL · contact PI
STEM CELL MOBILIZATION TO ENHANCE TISSUE REGENERATION$529,908
R01 · FY2005 · HL
Molecular Pathogenesis of Severe Congential Neutropenia$344,250
R01 · FY2005 · HL
G-CSF receptor in progenitor mobilization$306,000
R01 · FY2005 · HL
STEM CELL MOBILIZATION TO ENHANCE TISSUE REGENERATION$521,331
R01 · FY2004 · HL
Molecular Pathogenesis of Severe Congential Neutropenia$344,250
R01 · FY2004 · HL
G-CSF receptor in progenitor mobilization$306,000
R01 · FY2004 · HL
STEM CELL MOBILIZATION TO ENHANCE TISSUE REGENERATION$513,003
R01 · FY2003 · HL
G-CSF RECEPTOR AND PROGENITOR MOBILIZATION$247,084
R01 · FY2003 · HL
G-CSF RECEPTOR AND PROGENITOR MOBILIZATION$224,208
R01 · FY2002 · HL
G-CSF RECEPTOR AND PROGENITOR MOBILIZATION$217,677
R01 · FY2001 · HL
G-CSF RECEPTOR AND PROGENITOR MOBILIZATION$211,337
R01 · FY2000 · HL